Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 27:10:812781.
doi: 10.3389/fped.2022.812781. eCollection 2022.

Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review

Cechuan Deng  1   2 , Shanling Liu  1   2
Affiliations
Review

Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review

Cechuan Deng et al. Front Pediatr. .

Abstract

A paradigm shift in noninvasive prenatal screening has been made with the discovery of cell-free fetal DNA in maternal plasma. Noninvasive prenatal screening is primarily used to screen for fetal aneuploidies, and has been used globally. Fetal fraction, an important parameter in the analysis of noninvasive prenatal screening results, is the proportion of fetal cell-free DNA present in the total maternal plasma cell-free DNA. It combines biological factors and bioinformatics algorithms to interpret noninvasive prenatal screening results and is an integral part of quality control. Maternal and fetal factors may influence fetal fraction. To date, there is no broad consensus on the factors that affect fetal fraction. There are many different approaches to evaluate this parameter, each with its advantages and disadvantages. Different fetal fraction calculation methods may be used in different testing platforms or laboratories. This review includes numerous publications that focused on the understanding of the significance, influencing factors, and interpretation of fetal fraction to provide a deeper understanding of this parameter.

Keywords: cell-free fetal DNA; fetal fraction; genetic counseling; molecular genetics; noninvasive prenatal screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of noninvasive prenatal screening.
Figure 2
Figure 2
Management procedures of pregnant women with failed results owing to a low FF.
See this image and copyright information in PMC

References

    1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. . Presence of fetal DNA in maternal plasma and serum. Lancet. (1997) 350:485–7. 10.1016/S0140-6736(97)02174-0 - DOI - PubMed
    1. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA. (2011) 306:627–36. 10.1001/jama.2011.1114 - DOI - PMC - PubMed
    1. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, et al. . Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. (2008) 105:20458–63. 10.1073/pnas.0810641105 - DOI - PMC - PubMed
    1. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA. (2008) 105:16266–71. 10.1073/pnas.0808319105 - DOI - PMC - PubMed
    1. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. . DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. (2011) 13:913–20. 10.1097/GIM.0b013e3182368a0e - DOI - PubMed

LinkOut - more resources